|
|
| Line 13: |
Line 13: |
| | <!--add ?action=raw&ctype=text/css when using Css--> | | <!--add ?action=raw&ctype=text/css when using Css--> |
| | <!-- Bootstrap CSS V --> | | <!-- Bootstrap CSS V --> |
| − | <link rel="stylesheet" href="https://2015.igem.org/Template:Peking/CSS?action=raw&ctype=text/css" type="text/css" media="screen"> | + | <link rel="stylesheet" href="https://2015.igem.org/Template:Peking/new?action=raw&ctype=text/css" type="text/css" media="screen"> |
| − | <!-- Font Awesome CSS V -->
| + | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Style/new?action=raw&ctype=text/css" media="screen"> |
| − | <!--<link rel="stylesheet" href="https://2015.igem.org/Template:Peking/CSS/Font?action=raw&ctype=text/css" type="text/css" media="screen">-->
| + | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Responsive/new?action=raw&ctype=text/css" media="screen"> |
| − | <!-- Margo CSS Styles V-->
| + | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Animate/new?action=raw&ctype=text/css" media="screen"> |
| − | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Style?action=raw&ctype=text/css" media="screen"> | + | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Blue/new?action=raw&ctype=text/css " title="blue" media="screen" /> |
| − | <!-- Responsive CSS Styles -->
| + | |
| − | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Responsive?action=raw&ctype=text/css" media="screen"> | + | |
| − | <!-- Css3 Transitions Styles -->
| + | |
| − | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Animate?action=raw&ctype=text/css" media="screen"> | + | |
| − | <!-- Color CSS Styles -->
| + | |
| − | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Blue?action=raw&ctype=text/css " title="blue" media="screen" /> | + | |
| | | | |
| | <style type="text/css"> | | <style type="text/css"> |
| Line 86: |
Line 80: |
| | | | |
| | <!-- Start Navigation List --> | | <!-- Start Navigation List --> |
| − | <ul id="nav-top" class="nav navbar-nav navbar-right " style="padding-bottom:15px;padding-top:10px"> | + | <ul class="nav navbar-nav navbar-right " style="padding-bottom:15px;height:88px;padding-top:10px"> |
| | <li> | | <li> |
| − | <a href="https://2015.igem.org/Team:Peking">Home</a> | + | <a class="active" href="https://2015.igem.org/Team:Peking/JudgingCriteria">Achievements</a> |
| − | </li>
| + | |
| − | <li>
| + | |
| − | <a href="#" class="active">Achievements</a>
| + | |
| | <ul class="dropdown"> | | <ul class="dropdown"> |
| − | <li><a href="#" class="active">Judging Criteria</a> | + | <li><a class="active" href="https://2015.igem.org/Team:Peking/JudgingCriteria">Judging Criteria</a> |
| | </li> | | </li> |
| | <li><a href="https://2015.igem.org/Team:Peking/Parts">Parts</a> | | <li><a href="https://2015.igem.org/Team:Peking/Parts">Parts</a> |
| Line 106: |
Line 97: |
| | <li><a href="https://2015.igem.org/Team:Peking/Design">Overview</a> | | <li><a href="https://2015.igem.org/Team:Peking/Design">Overview</a> |
| | </li> | | </li> |
| − | <li><a href="#">Background</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Design/PC_Reporter">Paired<span style="text-transform:lowercase"> d</span>Cas9 Reporter</a> |
| | + | </li> |
| | + | <li><a href="https://2015.igem.org/Team:Peking/Design/Isothermal">Iso-<span style="text-transform:lowercase">t</span>hermal Amplification</a></li> |
| | + | <li><a href="https://2015.igem.org/Team:Peking/Device">Hardware</a> |
| | </li> | | </li> |
| − | <li><a href="#">CRIPSR</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Design/Speculation">Speculation</a> |
| − | </li>
| + | |
| − | <li><a href="#">Isothermal PCR</a>
| + | |
| − | </li>
| + | |
| − | <li><a href="#">B. subtillis</a>
| + | |
| − | </li>
| + | |
| − | <li><a href="#">Device</a>
| + | |
| | </li> | | </li> |
| | </ul> | | </ul> |
| | </li> | | </li> |
| | <li> | | <li> |
| − | <a href="https://2015.igem.org/Team:Peking/Modeling">Modelling</a> | + | <a href="https://2015.igem.org/Team:Peking/Modeling">Modeling</a> |
| | <ul class="dropdown"> | | <ul class="dropdown"> |
| − | <li><a href="#">Link 1</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Modeling">Array Design</a> |
| | </li> | | </li> |
| − | <li><a href="#">Link 2</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Modeling/Analysis">Analysis algorithm</a> |
| | </li> | | </li> |
| | </ul> | | </ul> |
| | </li> | | </li> |
| | <li> | | <li> |
| − | <a href="https://2015.igem.org/Team:Peking/Practices">Human Practice</a> | + | <a href="https://2015.igem.org/Team:Peking/Practices">Practices</a> |
| | <ul class="dropdown"> | | <ul class="dropdown"> |
| − | <li><a href="#">Link 1</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Practices">Overview</a> |
| | </li> | | </li> |
| − | <li><a href="#">Link 2</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Practices/Background">TB Facts</a> |
| | + | </li> |
| | + | <li><a href="https://2015.igem.org/Team:Peking/Practices/Consultation">Consultation and Interview</a> |
| | </li> | | </li> |
| − | <li><a href="#">Link 3</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Practices/Engagement">Public Engagement</a> |
| | </li> | | </li> |
| − | <li><a href="#">Link 4</a> | + | <li><a href="https://2015.igem.org/Team:Peking/Practices/Outreach">Ethics and Economics Issues</a> |
| | </li> | | </li> |
| | </ul> | | </ul> |
| | </li> | | </li> |
| | <li> | | <li> |
| − | <a href="https://2015.igem.org/Team:Peking/Team">Lab</a> | + | <a href="https://2015.igem.org/Team:Peking/Team">Lab</a> |
| | <ul> | | <ul> |
| | <li><a href="https://2015.igem.org/Team:Peking/Team">Team</a> | | <li><a href="https://2015.igem.org/Team:Peking/Team">Team</a> |
| Line 228: |
Line 218: |
| | <!-- Classic Heading --> | | <!-- Classic Heading --> |
| | <h3 class="classic-title"><span>Judging Criteria</span></h3> | | <h3 class="classic-title"><span>Judging Criteria</span></h3> |
| − |
| + | <div> |
| − | <!-- Some Text --> | + | <P>We are very proud of the many achievements we have made in this summer. Here is a compilation of our feats! </P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi.</p>
| + | <P>1. We successfully designed and constructed a paired dCas9 reporter (PC Reporter) that can convert specific sequence information into light signal; the detailed characterization showed that it was effective for real TB nucleic acid diagnosis. (For more details, <a href="https://2015.igem.org/Team:Peking/Design/PC_Reporter">click here</a>)</P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi. </p>
| + | <P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi. </p>
| + | 2. We submitted 21 high-quality and well-characterized Standard Biobricks, including a set of paired dCas9 reporter collection. (For more details, <a href="https://2015.igem.org/Team:Peking/Parts">click here</a>)</P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi. </p>
| + | <P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi. </p>
| + | 3. We successfully designed an MTB multi-marker array to deal with challenges from clinical practices, such as strain mutations, sample variations, and other uncontrollable environmental factors. (For more details, <a href="https://2015.igem.org/Team:Peking/Modeling">click here</a>)</P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi.</p>
| + | <P> |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi. </p>
| + | 4. A portable and affordable Ultra-Sensitive Bioluminescence Detector (USB Detector) was built for convenient detection of light read-outs. (For more details, <a href="https://2015.igem.org/Team:Peking/Device">click here</a>) |
| − | <p>At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi.</p>
| + | </P> |
| | + | <P>5. We invented two new isothermal amplification methods to expand existing isothermal PCR methods. (For more details, <a href="https://2015.igem.org/Team:Peking/Design/Isothermal">click here</a>) |
| | + | </P> |
| | + | <P>6. We visited doctors and experts from the research institute for TB control and local hospitals to learn the situation of TB and their demands for TB detection. After finishing main work, we presented them our achievements and got their feedback. (For more details, <a href="https://2015.igem.org/Team:Peking/Practices/Consultation">click here</a>) |
| | + | </P> |
| | + | <P>7. We did an ethics discussion and finished an economic report about future TB detection. We enhanced the public education about TB and synthetic biology by doing survey, distributing brochures and giving lectures. (For more details, <a href="https://2015.igem.org/Team:Peking/Practices/Outreach">click here</a>) |
| | + | </P> |
| | + | <P>8. We helped and collaborated with 5 other iGEM teams by guiding new teams, discussing about project design and technical skills and sharing DNA materials. (For more details, <a href="https://2015.igem.org/Team:Peking/Collaborations">click here</a>) |
| | + | </P> |
| | + | <P>9. We successfully hold CCiC (Conference of China iGEMer Committee). It's a large-scale competition-free jamboree for 34 teams, providing participants with an opportunity for meaningful exchanges in ideas enhanced and problem solving. (For more details, <a href="https://2015.igem.org/Team:Peking/Collaborations">click here</a>) |
| | + | </P> |
| | + | <P>Therefore, we believe that we deserve a Gold Medal Prize.</P> |
| | + | |
| | </div> | | </div> |
| | | | |
